Insider Transactions in Q2 2023 at Integra Lifesciences Holdings Corp (IART)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Open market or private purchase
|
Direct |
2,640
+5.15%
|
$97,680
$37.89 P/Share
|
|
Jun 01
2023
|
Jan De Witte President & CEO |
BUY
Open market or private purchase
|
Direct |
7,792
+37.84%
|
$296,096
$38.5 P/Share
|
|
May 13
2023
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
185
-0.15%
|
$9,065
$49.05 P/Share
|
|
May 12
2023
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,302
+4.09%
|
-
|
|
May 12
2023
|
Shaundra Clay Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,486
+25.33%
|
-
|
|
May 12
2023
|
Barbara B Hill Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,117
+3.37%
|
-
|
|
May 12
2023
|
Raymond G. Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,486
+9.01%
|
-
|
|
May 12
2023
|
Renee Wonlai Lo Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,486
+37.57%
|
-
|
|
May 12
2023
|
Christian S Schade Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,486
+7.57%
|
-
|
|
May 12
2023
|
Stuart Essig Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
5,505
+0.48%
|
-
|